VIBERZI

This brand name is authorized in United States. It is also authorized in Canada, New Zealand.

Active ingredients

The drug VIBERZI contains one active pharmaceutical ingredient (API):

1	Eluxadoline UNII 45TPJ4MBQ1 - ELUXADOLINE
	Eluxadoline is a locally acting, mixed mu opioid receptor (μOR) agonist and delta opioid receptor (δOR) antagonist. Eluxadoline is also an agonist at the kappa opioid receptor (κOR). Eluxadoline has demonstrated efficacy in normalizing GI transit and defecation in several models of stress induced or post GI inflammation-altered GI function in animals.
	Read more about Eluxadoline

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
VIBERZI Film-coated tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A07DA06		A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07D Antipropulsives → A07DA Antipropulsives
Discover more medicines within A07DA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02460890, 02460904
NZ	Medicines and Medical Devices Safety Authority	18681, 18682
US	FDA, National Drug Code	61874-075, 61874-100